enGene Therapeutics, Inc. (ENGN)
1.81
+0.03
(+1.69%)
USD |
NASDAQ |
Aug 24, 16:00
1.82
+0.01
(+0.55%)
After-Hours: 20:00
enGene Therapeutics Market Cap : 121.25M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 119.24M |
| August 20, 2026 | 118.57M |
| August 19, 2026 | 123.93M |
| August 18, 2026 | 115.22M |
| August 17, 2026 | 113.88M |
| August 14, 2026 | 113.88M |
| August 13, 2026 | 113.21M |
| August 12, 2026 | 113.88M |
| August 11, 2026 | 121.92M |
| August 10, 2026 | 117.23M |
| August 07, 2026 | 120.58M |
| August 06, 2026 | 120.58M |
| August 05, 2026 | 120.58M |
| August 04, 2026 | 119.91M |
| August 03, 2026 | 118.57M |
| July 31, 2026 | 119.91M |
| July 30, 2026 | 117.90M |
| July 29, 2026 | 119.91M |
| July 28, 2026 | 117.90M |
| July 27, 2026 | 117.90M |
| July 24, 2026 | 121.92M |
| July 23, 2026 | 126.61M |
| July 22, 2026 | 123.93M |
| July 21, 2026 | 129.29M |
| July 20, 2026 | 125.27M |
| Date | Value |
|---|---|
| July 17, 2026 | 121.92M |
| July 16, 2026 | 128.62M |
| July 15, 2026 | 127.28M |
| July 14, 2026 | 126.95M |
| July 13, 2026 | 124.60M |
| July 10, 2026 | 127.28M |
| July 09, 2026 | 128.62M |
| July 08, 2026 | 124.60M |
| July 07, 2026 | 128.62M |
| July 06, 2026 | 127.95M |
| July 02, 2026 | 119.24M |
| July 01, 2026 | 117.90M |
| June 30, 2026 | 115.89M |
| June 29, 2026 | 119.24M |
| June 26, 2026 | 117.23M |
| June 25, 2026 | 118.57M |
| June 24, 2026 | 117.23M |
| June 23, 2026 | 114.55M |
| June 22, 2026 | 113.21M |
| June 18, 2026 | 115.22M |
| June 17, 2026 | 116.56M |
| June 16, 2026 | 117.23M |
| June 15, 2026 | 118.57M |
| June 12, 2026 | 108.52M |
| June 11, 2026 | 109.86M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals, Inc. | 2.204B |
| Medicus Pharma Ltd. | 15.64M |
| Sirona Biochem Corp. | 1.320M |
| Xenon Pharmaceuticals, Inc. | 5.857B |
| Psyence Biomedical Ltd. | 9.632M |
Market Cap Related Metrics
| PEG Ratio | -0.0256 |
| Price to Book Value | 0.4752 |
| Price | 1.81 |
| Earnings Yield | -120.5% |
| PEGY Ratio | -0.0256 |